Techniques for fertility preservation in patients with breast cancer.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 19125006)

Published in Curr Opin Obstet Gynecol on February 01, 2009

Authors

Lara Dunn1, Kevin R Fox

Author Affiliations

1: University of Pennsylvania School of Medicine, and Abramson Cancer Center of Univerisity of Pennsylvania, Pennsylvania, USA.

Articles by these authors

Characteristics associated with differences in survival among black and white women with breast cancer. JAMA (2013) 3.35

Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res (2007) 2.25

CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients. Sci Transl Med (2012) 2.22

Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev (2010) 1.90

HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.46

Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer (2005) 1.22

Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance. Cancer Res (2007) 1.08

Hypereosinophilia associated with cardiac rhabdomyosarcoma. Am J Hematol (2003) 0.83

Racial disparities in colon cancer survival: a matched cohort study. Ann Intern Med (2014) 0.83

Optimizing outcomes with bevacizumab by better targeting patients and tumors. Oncology (Williston Park) (2009) 0.76

Prescribing adjuvant letrozole to patients well after the completion of tamoxifen: a good idea? Curr Oncol Rep (2009) 0.75

Avoiding the use of anthracyclines in the adjuvant therapy of breast cancer: the "TC" (docetaxel and cyclophosphamide) regimen. Curr Oncol Rep (2008) 0.75

Duration of chemotherapy for early stage breast cancer: have we reached the limit? What is the survival impact of amenorrhea? Curr Treat Options Oncol (2010) 0.75

Differences in breast cancer survival by race--reply. JAMA (2013) 0.75

The role of MRI scanning of the contralateral breast in women with newly diagnosed breast cancer: a new care standard or not? Curr Oncol Rep (2008) 0.75

Adding bevacizumab to paclitaxel in the first-line treatment of metastatic breast cancer. Curr Oncol Rep (2009) 0.75

HER2 blockade: is combination therapy better than monotherapy? Curr Treat Options Oncol (2010) 0.75